Skip to main content

Tango Therapeutics

Tango Therapeutics Inc is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The firm focuses on the discovery and development of novel targeted cancer therapies using proprietary functional genomic discovery platforms. Its core research portfolio targets synthetic lethality to identify and attack cancer vulnerabilities across various tumor types. Revenue is primarily generated through research collaborations, corporate partnerships, and pharmaceutical licensing agreements. The company serves oncology researchers, healthcare institutions, and clinical development networks globally. Tango Therapeutics Inc is a publicly traded entity listed on the Nasdaq Stock Market.

10 of the funds FundTelligence covers report a position in Tango Therapeutics.

Legal name
Tango Therapeutics Inc
Sector
Health Care
Country
United States
Funds holding it
10
Exposure themes
Precision Medicine & Genomics, Precision Oncology, Precision Therapeutics

Funds holding Tango Therapeutics

Showing the 8 largest of 10 funds holding it.

Loading...